Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission? [Hematologic Malignancy]
Conclusion
The similarities in outcomes between patients in MRD-positive morphologic remission and those with active disease at the time of HCT support the use of treatment algorithms that use MRD- rather than morphology-based disease assessments.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Araki, Wood, Othus, Radich, Halpern, Zhou, Mielcarek, Estey, Appelbaum, Walter Tags: Leukemia Hematologic Malignancy Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Hematology | Leukemia | Statistics | Transplants